Skip to main content

and
  1. Article

    Open Access

    Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis

    Gastro esophageal reflux (GER) is common in cystic fibrosis (CF) and may contribute to lung disease. Approximately 50% of patients with cystic fibrosis are being treated with proton pump inhibitors (PPIs).

    Emily DiMango, Patricia Walker, Claire Keating, Maria Berdella in BMC Pulmonary Medicine (2014)